Algernon Pharmaceuticals Inc (AGNPF)

[GVX808]

Patience is the name of the game at this point. These things take a ton of time. Algernon is just lucky to have the current pandemic accelerating the process.

Share price is hinging on the data that comes out of SK.

We will also see a bump from Australia/U.S. COVID-19 Phase 2B/3 approval, but good results will send the share price into orbit. However, bad data may have the same effect in the opposite direction.

Unfortunately, all we can do is sit back and wait for good data.
However, based on the facts, the odds of a happy ending to this story are looking good!